| Previous Close | 0.0600 |
| Open | 0.0550 |
| Bid | 0.0550 x 0 |
| Ask | 0.0600 x 0 |
| Day's Range | 0.0550 - 0.0600 |
| 52 Week Range | 0.0200 - 0.2100 |
| Volume | 55,000 |
| Avg. Volume | 654,701 |
| Market Cap | 7.693M |
| Beta (5Y Monthly) | -11.87 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0140 |
| Earnings Date | Feb. 28, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
Lattice Biologics Ltd. Reports Fourth Quarter and Year End 2020 Highlights
Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) ("Lattice Biologics" or the "Company") announces financial results for Q4 2020 and year end 2020.
- Business Wire
Lattice Unaware of Any Material Change
Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) ("Lattice Biologics" or the "Company") at the request of the Investment Industry Regulatory Organization of Canada ("IIROC"), wishes to confirm that it is not aware of any material, undisclosed information related to the Company that would account for the recent increase in the market price and trading volume of its common shares.
- Business Wire
COVID19 UPDATE – Lattice Biologics Announces Cessation of Patient Recruitment
Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) ("Lattice Biologics" or the "Company") announces cessation of patient recruitment for its Phase 1 study.
© 2021 Verizon Media. All rights reserved.
